{"id":396866,"date":"2025-04-03T08:11:16","date_gmt":"2025-04-03T06:11:16","guid":{"rendered":"https:\/\/medizinonline.com\/durvalumab-approved-as-first-immunotherapy-for-patients-with-ls-sclc\/"},"modified":"2025-04-03T08:14:08","modified_gmt":"2025-04-03T06:14:08","slug":"durvalumab-approved-as-first-immunotherapy-for-patients-with-ls-sclc","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/durvalumab-approved-as-first-immunotherapy-for-patients-with-ls-sclc\/","title":{"rendered":"Durvalumab approved as first immunotherapy for patients with LS-SCLC"},"content":{"rendered":"\n<p><strong>Durvalumab has been approved as a monotherapy in Switzerland for the treatment of adult patients with unresectable small cell lung cancer (LS-SCLC, <em>limited-stage small cell lung cancer) <\/em>whose disease has not progressed after platinum-based chemoradiotherapy (CRT) [1]. It offers a new treatment option that has been shown to improve the survival of patients with this aggressive form of lung cancer. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fdurvalumab-approved-as-first-immunotherapy-for-patients-with-ls-sclc%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Durvalumab has been approved as a monotherapy in Switzerland for the treatment of adult patients with unresectable small cell lung cancer (LS-SCLC, limited-stage small cell lung cancer) whose disease has&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fdurvalumab-approved-as-first-immunotherapy-for-patients-with-ls-sclc%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396869,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Small cell lung carcinoma","footnotes":""},"category":[11548,11530,11370,11455,11503],"tags":[37774,23700,13546,81891,11705,20495,23082],"powerkit_post_featured":[],"class_list":["post-396866","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-market-medicine","category-oncology","category-pneumology","category-studies","tag-chemoradiotherapy","tag-durvalumab-en","tag-immunotherapy","tag-lc-sclc-en","tag-lung-cancer-en","tag-sclc-en","tag-small-cell-lung-cancer-en","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-17 20:38:46","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":396860,"slug":"durvalumab-premiere-immunotherapie-approuvee-pour-les-patients-atteints-de-ls-sclc","post_title":"Durvalumab, premi\u00e8re immunoth\u00e9rapie approuv\u00e9e pour les patients atteints de LS-SCLC","href":"https:\/\/medizinonline.com\/fr\/durvalumab-premiere-immunotherapie-approuvee-pour-les-patients-atteints-de-ls-sclc\/"},"it_IT":{"locale":"it_IT","id":396854,"slug":"durvalumab-e-stato-approvato-come-prima-immunoterapia-per-i-pazienti-con-ls-sclc","post_title":"Durvalumab \u00e8 stato approvato come prima immunoterapia per i pazienti con LS-SCLC","href":"https:\/\/medizinonline.com\/it\/durvalumab-e-stato-approvato-come-prima-immunoterapia-per-i-pazienti-con-ls-sclc\/"},"pt_PT":{"locale":"pt_PT","id":396848,"slug":"durvalumab-aprovado-como-primeira-imunoterapia-para-doentes-com-ls-sclc","post_title":"Durvalumab aprovado como primeira imunoterapia para doentes com LS-SCLC","href":"https:\/\/medizinonline.com\/pt-pt\/durvalumab-aprovado-como-primeira-imunoterapia-para-doentes-com-ls-sclc\/"},"es_ES":{"locale":"es_ES","id":396842,"slug":"durvalumab-aprobado-como-primera-inmunoterapia-para-pacientes-con-ls-sclc","post_title":"Durvalumab aprobado como primera inmunoterapia para pacientes con LS-SCLC","href":"https:\/\/medizinonline.com\/es\/durvalumab-aprobado-como-primera-inmunoterapia-para-pacientes-con-ls-sclc\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/396866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=396866"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/396866\/revisions"}],"predecessor-version":[{"id":398117,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/396866\/revisions\/398117"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/396869"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=396866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=396866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=396866"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=396866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}